IRIS
RUSSO, Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.519
NA - Nord America 6.097
AS - Asia 3.998
SA - Sud America 1.348
AF - Africa 123
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.093
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.966
RU - Federazione Russa 3.894
SG - Singapore 1.688
BR - Brasile 1.167
CN - Cina 1.123
IE - Irlanda 921
SE - Svezia 808
HK - Hong Kong 475
IT - Italia 421
DE - Germania 329
FR - Francia 256
VN - Vietnam 220
PL - Polonia 212
UA - Ucraina 206
FI - Finlandia 157
GB - Regno Unito 154
IN - India 110
AR - Argentina 60
MX - Messico 59
IQ - Iraq 52
BD - Bangladesh 42
ID - Indonesia 42
CA - Canada 41
TR - Turchia 39
ZA - Sudafrica 38
AT - Austria 34
EC - Ecuador 34
JP - Giappone 33
BE - Belgio 31
CO - Colombia 25
UZ - Uzbekistan 24
ES - Italia 21
NL - Olanda 20
VE - Venezuela 20
KE - Kenya 17
MA - Marocco 16
PK - Pakistan 16
AZ - Azerbaigian 15
CL - Cile 14
JO - Giordania 13
TN - Tunisia 12
PH - Filippine 11
NP - Nepal 10
SA - Arabia Saudita 10
UY - Uruguay 10
CI - Costa d'Avorio 9
IR - Iran 9
LV - Lettonia 9
MY - Malesia 9
DZ - Algeria 8
HN - Honduras 8
KZ - Kazakistan 8
PY - Paraguay 8
DO - Repubblica Dominicana 7
AL - Albania 6
IL - Israele 6
PE - Perù 6
RO - Romania 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
JM - Giamaica 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BY - Bielorussia 4
ET - Etiopia 4
KG - Kirghizistan 4
KR - Corea 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
LB - Libano 3
LT - Lituania 3
NG - Nigeria 3
NI - Nicaragua 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
EU - Europa 2
GE - Georgia 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
Totale 19.078
Salva come PNG Salva come JPEG
Città #
Moscow 1.134
Ashburn 1.054
Singapore 957
Dublin 919
Chandler 681
Dallas 517
Hong Kong 474
Jacksonville 421
Beijing 398
Nyköping 387
San Jose 216
Warsaw 207
The Dalles 175
Los Angeles 168
Princeton 167
Lauterbourg 143
Medford 143
Messina 132
Cambridge 129
Dearborn 126
Des Moines 122
Ann Arbor 110
São Paulo 96
Munich 72
New York 72
Boardman 69
Buffalo 67
Ho Chi Minh City 65
San Mateo 56
Bremen 55
Tianjin 53
Jinan 52
Redondo Beach 51
Council Bluffs 50
Wilmington 50
Shenyang 47
Hanoi 43
Guangzhou 36
Belo Horizonte 33
Santa Clara 33
Tokyo 32
Woodbridge 32
Brussels 31
Rio de Janeiro 31
Turku 31
Frankfurt am Main 30
Nuremberg 30
Pune 25
Baghdad 24
Jakarta 24
Orem 24
Catania 23
Hebei 23
Nanjing 23
Tashkent 23
Curitiba 22
Dong Ket 22
Haikou 22
Montreal 22
Brasília 21
Brooklyn 21
Houston 21
Seattle 21
Milan 19
Campinas 17
Mexico City 17
Chicago 16
Johannesburg 16
London 16
Mumbai 16
Nairobi 16
Porto Alegre 16
Shanghai 15
Vienna 15
Amsterdam 14
Baku 14
Denver 14
Falls Church 14
Poplar 14
Rome 14
Zhengzhou 14
Chennai 13
Istanbul 13
Lancaster 13
Ningbo 13
Quito 13
Shenzhen 13
Amman 12
Helsinki 12
Ribeirão Preto 12
San Francisco 12
Boston 11
Charlotte 11
Manchester 11
Norwalk 11
Phoenix 11
Salvador 11
Stockholm 11
Taizhou 11
Augusta 10
Totale 10.859
Salva come PNG Salva come JPEG
Nome #
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 261
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 223
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 211
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 196
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 195
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 194
Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice 191
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes. 188
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 187
.Frequence of FDB in a hypercholesterolemic population from east Sicily 186
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 183
Pimozide and pancreatic cancer in diabetic chorea: a case report 181
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 180
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 180
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 176
Ischemic stroke and reperfusion therapies in diabetic patients 169
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 166
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 163
Elevata prevalenza della colonizzazione da parte di Arcobacter spp. in soggetti asintomatici con diabete di tipo 2 160
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach. 159
Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus. 159
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 156
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 156
Correlates of total homocysteine plasma concentration in type 2 diabetes 154
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 154
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 152
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 151
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 149
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 149
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 148
Genomic Variations Affecting Biological Effects of Statins 148
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 148
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 147
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 146
Association of a Common Polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) Gene with Bone Phenotypes Depends on Plasma Folate Status 145
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 145
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 145
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 143
Artificial intelligence and big data in diabetes care: A position statement of the Italian association of medical diabetologists 143
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 142
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. 142
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2 141
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 140
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 140
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 140
Analoghi del Glucagon-like peptide-1: cosa ci riserva il futuro. 137
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 137
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 137
Livelli plasmatici di resistina e proteina C- reattiva nelle donne: ruolo del diabete di tipo 2 e della menopausa. 136
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 136
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 136
Livelli di TSH e parametri metabolici in soggetti diabetici di tipo 2 eutiroidei 134
3. High-density lipoprotein as a coronary heart disease risk factor and gene mutations affecting high-density lipoprotein cholesterol levels: Results from the Framingham Heart Study 134
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 133
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 133
Atherogenic dyslipidemia and diabetic nephropathy 131
Type 2 diabetes and cardiovascular risk in women. 129
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 128
Gli Standard di Cura terzo step: incretina + metformina. 127
ELEVATA PREVALENZA DELLA COLONIZZAZIONE DA PARTE DI ARCOBACTER P: IN SOGGETTI ASINTOMATICI CON DIABETE DI TIPO 2. 125
Resistin levels and inflammatory and endothelial dysfunction markers in obese postmenopausal women with type 2 diabetes mellitus 125
Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. 124
Recombinant Insulin in Type 2 Diabetes Treatment: Where Are We Now? 123
Livelli di resistina nelle donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 119
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 118
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 118
Diabetic kidney disease in the elderly: Prevalence and clinical correlates 117
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 116
Livelli di omocisteina, vitamina B12 e folati in soggetti con diabete mellito di tipo 2 con o senza neuropatia diabetica. Ruolo della metformina 116
RUOLO DELL'IPEROMOCISTEINEMIA E DEL GENOTIPO C677T DEL GENE DELLA METILENE TEDRAIDROFOLATO REDUTTASI (MTHFR)IN UNA POPOLAZIONE DI DIABETICI DI TIPO 2 CON E SENZA SINDROME METABOLICA 114
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 113
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 112
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 112
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting 111
A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: the amd annals initiative 110
IPEROMOCISTEINEMIA E RISCHIO CARDIOVASCOLARE NEL DIABETE: FANTASIA O REALTA'? 110
Necrobiosis lipoidica associated with Hashimoto's thyroiditis and positive detection of ANA and ASMA autoantibodies 110
Inflammatory markers in women with a recent history of gestational diabetes mellitus 109
Skin lesions in diabetes mellitus: prevalence and clinical correlations. 108
Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions 107
Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis 106
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes 105
POLIMORFISMO DEL GENE DELL'APOLIPOPROTEINA E E PATOLOGIA COLELITIASICA IN UNA POPOLAZIONE DEL SUD ITALIA 104
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study. 104
Biphasic insulin aspart in the treatment of type 2 diabetes mellitus 102
Ruolo dell’ipercisteinemia e del genotipo C677T del gene della metilene tetraidrifolato redattasi (MTHFR) in una popolazione di diabetici di tipo 2 con e senza Sindrome Metabolica 101
Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. 101
Beta cell stress in a 4-year follow-up of patients with type 2 diabetes: A longitudinal analysis of the BetaDecline Study 101
Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes. 100
Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD annals initiative 100
determinants of total homocysteine plasma levels in type 2 diabetes 100
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 99
LE DISLIPIDEMIE NEL PAZIENTE DIABETICO 99
Frequence of FDP in a hypercholesterolemic population from East Sicily 98
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. 98
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study 97
Methotrexate Increases Skeletal Muscle GLUT4 Expression and Improves Metabolic Control in Experimental Diabetes 97
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 96
Influence of CETP Taq IB polymorphism on lipid profile and HDL subpopulations distribution in women with and without diabetes 95
Menopause modulates homocysteine levels in diabetic and non-diabetic women. 95
Totale 13.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.305
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021259 0 0 0 0 0 0 0 0 0 88 106 65
2021/20221.111 7 98 10 47 35 10 89 42 25 276 124 348
2022/20232.677 194 198 138 216 207 254 26 175 1.159 19 62 29
2023/2024616 48 90 44 57 42 136 20 44 3 27 18 87
2024/20253.350 50 53 73 208 169 126 84 654 826 202 308 597
2025/20269.053 429 566 668 657 811 2.009 1.239 1.133 1.170 371 0 0
Totale 19.495